May 5 |
Zymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
|
May 3 |
Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript
|
May 2 |
Zymeworks files automatic mixed securities shelf
|
May 2 |
Zymeworks GAAP EPS of -$0.42 misses by $0.10, revenue of $10.03M misses by $6.4M
|
May 2 |
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
May 1 |
Zymeworks Q1 2024 Earnings Preview
|
Apr 30 |
Zymeworks Announces Participation in Upcoming Investor Conferences
|
Apr 28 |
We Think Zymeworks (NASDAQ:ZYME) Can Afford To Drive Business Growth
|
Apr 18 |
Buy Zymeworks Pioneering Cancer Treatments: Zanidatamab's Promising Data
|
Apr 11 |
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
|